A Phase 1-1b Study to Evaluate the Safety, Efficacy and Dosimetry of Study Drug A9-3408 in Subjects With Metastatic Melanoma

NCT07076550 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Melanoma Metastatic
Uveal Melanoma, Metastatic
Mucosal Melanoma

Interventions

DRUG: [225Ac]Ac-A9-3408
DIAGNOSTIC_TEST: [68Ga]Ga-A9T-3202

Sponsor

Alpha-9 Oncology USA Inc.